Hideaki Fujita Selected Research

Hideaki Fujita Research Topics

Disease

6	Infections 04/2024 - 11/2010
5	Vesicular Stomatitis 04/2024 - 12/2015
5	Neoplasms (Cancer) 01/2023 - 10/2013
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020 - 12/2015
2	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2008
2	Lung Neoplasms (Lung Cancer) 10/2013 - 05/2013
2	Experimental Melanoma 05/2011 - 06/2009
1	Wounds and Injuries (Trauma) 07/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Hypersensitivity (Allergy) 01/2022
1	Sick Building Syndrome 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Chronic Disease (Chronic Diseases) 11/2019
1	Type 2 Diabetes Mellitus (MODY) 11/2019
1	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 10/2017
1	Fibrosis (Cirrhosis) 10/2017
1	Hypertension (High Blood Pressure) 10/2017
1	Hypopigmentation (Hypomelanosis) 05/2011
1	Multiple Myeloma 06/2009
1	Lacunar Stroke 04/2003

Drug/Important Bio-Agent (IBA)

5	Glycoproteins (Glycoprotein)IBA 04/2024 - 12/2015
5	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2008
4	Antiviral Agents (Antivirals)IBA 04/2024 - 01/2019
3	Phosphotransferases (Kinase)IBA 01/2020 - 05/2013
2	Viral Envelope ProteinsIBA 04/2024 - 01/2022
2	Tyrosine (L-Tyrosine)FDA Link 04/2024 - 11/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 10/2017
2	GlycosphingolipidsIBA 01/2020 - 12/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2013 - 05/2013
2	Gefitinib (Iressa)FDA Link 10/2013 - 05/2013
2	Monophenol Monooxygenase (Tyrosinase)IBA 05/2011 - 06/2009
1	Immunoglobulin E (IgE)IBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 11/2022
1	CytokinesIBA 01/2022
1	dehydrocostus lactoneIBA 01/2021
1	costunolideIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2020
1	OligosaccharidesIBA 01/2020
1	globotrioseIBA 01/2020
1	MytiLec-1IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	SugarsIBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	SodiumIBA 10/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Polysaccharides (Glycans)IBA 12/2015
1	CaspasesIBA 12/2015
1	LectinsIBA 12/2015
1	Death Domain ReceptorsIBA 12/2015
1	IntegrinsIBA 10/2013
1	ErbB Receptors (EGF Receptor)IBA 10/2013
1	((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA 05/2013
1	Indicators and Reagents (Reagents)IBA 05/2011
1	16- hydroxy- 9- oxo- 10,12,14- octadecatrienoic acidIBA 05/2011
1	Ethanol (Ethyl Alcohol)IBA 05/2011
1	Cytidine DeaminaseIBA 11/2010
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 06/2009
1	Melanins (Melanin)IBA 06/2009
1	2'-hydroxy-2,4,4,7,4'-pentamethylflavanIBA 06/2009
1	acetylleucyl-leucyl-norleucinalIBA 11/2008
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2008
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2008
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2003

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2021
1	Air Bags (Airbags) 07/2023
1	Diet Therapy (Therapy, Diet) 11/2019
1	Drug Therapy (Chemotherapy) 01/2017